과제정보
이 논문은 2019년도 동덕여자대학교 연구비 지원에 의하여 수행된 것으로 이에 감사드립니다.
참고문헌
- Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015;132(17):1667-78. https://doi.org/10.1161/CIRCULATIONAHA.114.008720
- de Fatima Marinho de Souza M, Gawryszewski VP, Ordunez P, Sanhueza A, Espinal MA. Cardiovascular disease mortality in the americas: Current trends and disparities. Heart 2012;98(16):1207-12. https://doi.org/10.1136/heartjnl-2012-301828
- Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: A report from the american heart association. Circulation 2019;139(10):e56-e528.
- Jee SH, Jang Y, Oh DJ, et al. A coronary heart disease prediction model: the Korean Heart Study. BMJ open 2014;4(5):e005025. https://doi.org/10.1136/bmjopen-2014-005025
- Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: A systematic review. JAMA 2005;294(17):2203-9. https://doi.org/10.1001/jama.294.17.2203
- Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the US preventive services task force. JAMA 2016;316(19):2008-2024. https://doi.org/10.1001/jama.2015.15629
- Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333(20):1301-1307. https://doi.org/10.1056/NEJM199511163332001
- Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001;292(5519):1160-4. https://doi.org/10.1126/science.1059344
- Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol 2003;92(2):152-60. https://doi.org/10.1016/S0002-9149(03)00530-7
- Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 1998;81(5):582-7. https://doi.org/10.1016/s0002-9149(97)00965-x
- Rhee E, Kim HC, Kim JH, et al. 2018 guidelines for the management of dyslipidemia in Korea. Journal of Lipid and Atherosclerosis. 2019;8(2):78-131. https://doi.org/10.12997/jla.2019.8.2.78
- Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm-2018 executive summary. Endocr Pract 2018;24(1):91-120. https://doi.org/10.4158/cs-2017-0153
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111-88. https://doi.org/10.1093/eurheartj/ehz455
- Son KB, Bae S. Patterns of statin utilisation for new users and market dynamics in South Korea: A 13-year retrospective cohort study. BMJ open 2019;9(3):e026603. https://doi.org/10.1136/bmjopen-2018-026603
- Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016;37(39):2999-3058. https://doi.org/10.1093/eurheartj/ehw272
- Kim S, Han S, Rane PP, Qian Y, Zhao Z, Suh HS. Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea. PLoS One 2020;15(1):e0228472. https://doi.org/10.1371/journal.pone.0228472
- Kwon JE, Kim Y, Hyun S, et al. Cholesterol lowering effects of low-dose statins in Korean patients. J lipid Atheroscler 2014;3(1):21-28. https://doi.org/10.12997/jla.2014.3.1.21
- Naito R, Miyauchi K, Daida H. Racial differences in the cholesterollowering effect of statin. J Atheroscler Thromb 2017;24(1):19-25. https://doi.org/10.5551/jat.RV16004
- Korea Centers for Disease Control & Prevention. Chronic disease status and issues 2019. Available from:http://nih.go.kr/gallery.es?mid=a20503020000&bid=0003&b_list=9&act=view&list_no=144581&nPage=1&vlist_no_npage=2&keyField=&keyWord=&orderby=. Accessed May 01, 2021.
- Kim HJ, Kim Y, Cho Y, Jun B, Oh KW. Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: Results from the Korea National Health and Nutrition Examination Survey, 1998-2012. Int J Cardiol 2014;174(1):64-72. https://doi.org/10.1016/j.ijcard.2014.03.163